| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |